Narjes Tavoosi, Rebecca L. Davis-Harrison, Taras V. Pogorelov, Y. Zenmei
Ohkubo, Mark J. Arcario, Mary C. Clay, Chad M. Rienstra, Emad Tajkhorshid,
and James H. Morrissey.
Molecular determinants of phospholipid synergy in blood clotting.
Journal of Biological Chemistry, 286:23247-23253, 2011.
(PMC: 3123091)
TAVO2011-ET
Many regulatory processes in biology involve reversible association
of proteins with membranes. Clotting proteins bind to
phosphatidylserine (PS) on cell surfaces, but a clear picture of
this interaction has yet to emerge. We present a novel explanation
for membrane binding by GLA domains of clotting proteins,
supported by biochemical studies, solid-state NMR analyses,
and molecular dynamics simulations. The model invokes a
single “phospho-L-serine-specific” interaction and multiple
“phosphate-specific” interactions. In the latter, the phosphates
in phospholipids interact with tightly bound Ca in GLA
domains. We show that phospholipids with any headgroup
other than choline strongly synergize with PS to enhance factor
X activation. We propose that phosphatidylcholine and sphingomyelin
(the major external phospholipids of healthy cells) are
anticoagulant primarily because their bulky choline headgroups
sterically hinder access to their phosphates. Following cell damage
or activation, exposed PS and phosphatidylethanolamine
collaborate to bind GLA domains by providing phospho-L-serine-
specific and phosphate-specific interactions, respectively.